These statements come at a time when Anthropic is looking for new investors for a large funding round that could value the company at $40 billion, reflecting the increasing interest in this promising field. Amodei’s optimistic vision aligns with the expectations of other leaders in the artificial intelligence field such as Sam Altman from OpenAI and Demis Hassabis from DeepMind – a Google subsidiary – who recently won the Nobel Prize in Chemistry, also believing that artificial intelligence could be the solution to curing all diseases in the future.
